Default Category
-
Tweeter etc. (Spanish version)
Gourville, John T.; Wu, GeorgeCase HBS-502S18MarketingIn the early 1990s, Tweeter etc., a small regional retailer of higher-end audio and video equipment, faced increasing competitive pricing pressures from several large regional and national consumer electronics chains. In response, in 1993, they introduced "Automatic Price Protection" (APP) as the cornerstone of a strategy to restore price credibility in the minds of consumers. Under APP, Tweeter monitored local newspaper ads and automatically mai...Starting at €8.20
-
Ti-Tech (B)
Shapiro, Benson P.; Gourville, John T.Case HBS-508096-EMarketingThis case concerns the selection and scheduling of orders by a small industrial titanium fabricator that recently has been plagued by poor deliveries and a lack of capacity. At the time of the case, Ti-Tech must decide which of four orders to accept, with capacity making it impossible to accept all four. Each order represents a different mix of labor, revenues, and potential future work. The case forces the student to choose among the four orders...Starting at €5.74
-
Hybrid Electric Vehicles: A 2011 Update
Gourville, John T.Case HBS-511125-EMarketingThis case is an addendum that updates HBS Case No. 502-025, "The Future of Hybrid Electric Cars." It covers the 10 years, 2001 to 2011.Starting at €8.20
-
Chances Are Course Selection at HBS and at Kellogg
Halaburda, Hanna; Sesia, AldoCase HBS-711417-EStrategyThe case describes two alternative elective course assignment procedures: Harvard Business School's lottery-based system and Kellogg Graduate School of Management's bidding-based system. The case has been designed to discuss the benefits and drawbacks of each system and their desirability (or lack thereof) depending on the context (the broader business system) within which they are implemented. The case also describes the draft used by the NBA to...Starting at €8.20
-
Biopure Corp. (Spanish version)
Gourville, John T.Case HBS-502S01MarketingIt is early 1998 and Biopure Corp., a small biopharmaceutical firm with no sales revenues in its ten-year history, has just received government approval to release Oxyglobin, a revolutionary new "blood substitute" designed to replace the need for donated animal blood in the veterinary market. A virtually identical product for the human market, Hemopure, is in the final stages of testing by Biopure and is expected to gain approval within one to tw...Starting at €8.20
-
Cabot Pharmaceuticals, Inc. (Spanish version)
Cespedes, Frank V.; Gourville, John T.Case HBS-511S04MarketingTraces the 12-year career of a pharmaceutical salesperson, Bob Marsh, from recruitment to termination. Marsh has had an uneven career with Cabot Pharmaceuticals and eventually is asked to resign. Following his termination, a number of Marsh's former customers complain vigorously, and Cabot's vice president of sales is asked to investigate the matter and to decide what, if anything, to do about it. The case raises issues in aligning strategy and s...Starting at €8.20
-
Developing an App for That, Teaching Note
Halaburda, Hanna; Gans, JoshuaTeaching Note HBS-711535-EStrategyTeaching Note for 711415.Starting at €0.00
-
Developing an App for That
Halaburda, Hanna; Gans, Joshua; Burbank, NathanielCase HBS-711415-EStrategyAt a time when ever-rising smartphone sales are driven as much by demand for devices that run must-have third-party apps as by the quality of traditional voice and data services, there is a myriad of challenges facing the software developer who is looking to choose which mobile development software platform to invest in. Written from the perspective of an established consumer bank that is about to commence development on its first downloadable ap...Starting at €8.20
-
New York Life and Immediate Annuities
Rotemberg, Julio J.; Gourville, John T.Case HBS-510040-EMarketingBy positioning Immediate Annuities as "guaranteed lifetime income," New York Life has built itself a $1.4 billion per year business by 2009. However, to make Immediate Annuities a mainstream financial product for retirees, New York Life must understand why many retirees are reluctant to buy them and many agents are reluctant to sell them.Starting at €8.20
-
Analyzing Relative Costs (Spanish version)
Rivkin, Jan W.; Halaburda, HannaCase HBS-713S11Strategyto anticipate how a rival is likely to react to a price change; to predict how a price war may evolve; to test whether a cost advantage it believes it has is real and sustainable; to decide how low a company must bid in order to win a competitive contract from a rival; to identify opportunities for internal cost reduction; to estimate, in the context of an acquisition, how much the costs of an acquired company might be reduced and what a reasona...Starting at €8.20